Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Chorionic villus sampling Stories

2014-03-19 04:21:22

DUBLIN, March 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tdmwb8/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Report" [http://www.researchandmarkets.com/research/tdmwb8/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal testing is increasingly being adopted by high risk pregnant women for the...

2013-11-01 16:23:38

SAN JOSE, Calif., Nov. 1, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., maker of the Harmony(TM) Prenatal Test, announced today that it has been selected as a key provider of non-invasive prenatal testing (NIPT) services in the majority of the 28 comprehensive Prenatal Diagnosis Centers (PDC) throughout the State of California. The Harmony test, which is the most widely used NIPT globally, is being offered to pregnant women as part of the California Prenatal Screening Program at no...

Simple Blood Test Is Less Invasive, More Precise Down’s Syndrome Test
2013-06-08 08:05:18

redOrbit Staff & Wire Reports — Your Universe Online Scientists at King´s College London have developed a new, non-invasive blood test that they claim can identify with 99 percent certainty whether or not an unborn child will have Down´s Syndrome. According to Nick Collins, Science Correspondent with The Telegraph, currently pregnant mothers typically undergo a screening while undergoing their 12-week ultrasound scan. This scan is used to determine the potential risk that the...

2012-12-13 12:24:30

What Parents Need To Know About These New Tests NEW YORK, Dec. 13, 2012 /PRNewswire-USNewswire/ -- New prenatal tests can give some parents piece of mind - sooner and with greater accuracy and less risk of miscarriage than current tests - that the baby they're expecting doesn't have a disorder. The new tests, which use fetal DNA suspended in the mother's blood, can test for chromosomal disorders such as Down syndrome (trisomy 21) and trisomy 18, and Rh blood incompatibility. They also...

Genetic Test Reveals More About Potential Birth Defects Than Conventional Methods
2012-12-06 11:43:12

Lawrence LeBlond for redOrbit.com - Your Universe Online Two new papers published in the New England Journal of Medicine (NEJM) show that genetic testing in early pregnancy reveals far more about potential birth defects and stillbirth risk than current prenatal testing does, based on a multi-center clinical trial using both methods. The clinical trials showed that 6 percent of certain fetuses declared normal by conventional prenatal tests were found to have genetic abnormalities using...

2012-08-27 02:25:42

SAN JOSE, Calif., Aug. 27, 2012 /PRNewswire/ -- A study published in The Journal of Maternal-Fetal and Neonatal Medicine demonstrates that the fraction of fetal cell-free DNA (cfDNA) in maternal blood is unaffected by the mother's presumed risk for trisomy, offering support for the use of non-invasive prenatal testing (NIPT) for detecting genetic conditions such as Down syndrome in a broad patient population. Lead and senior authors of the study were Dr. Herb Brar, Director of Riverside...

2012-06-05 02:28:26

MOUNTAIN VIEW, Calif., June 5, 2012 /PRNewswire/ -- Prenatal testing is an available choice for pregnant women around the world to obtain information at their discretion about the fetus they are carrying. Women may choose to detect chromosome abnormalities in the fetus. For example, mothers-to-be are often told by their OBGYNs about the increased risk of chromosomal abnormality with advanced maternal age. In the United States, the trend of increasing maternal age for women may also increase...

First-trimester Blood Test Reveals Fetal Gender
2012-01-04 05:57:00

A new South Korean study could pave the way for a simple, non-invasive test that predicts fetal gender as early as the first trimester of pregnancy. The researchers discovered that various ratios of two enzymes (DYS14/GAPDH), which can be extracted from a pregnant mother's blood, indicate whether the baby will be a boy or a girl. "Generally, early fetal gender determination has been performed by invasive procedures such as chorionic villus sampling or amniocentesis. However, these...

2011-10-17 14:45:26

A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice. The test can be offered as early as 10 weeks of pregnancy to women who have been identified as being at high risk for Down syndrome. These are the results of an international, multicenter study published online today in the journal Genetics in Medicine. The study, the largest and most...

2011-04-26 07:00:00

SAN CARLOS, Calif., April 26, 2011 /PRNewswire/ -- Verinata Health, Inc., (Verinata) a privately-held company dedicated to maternal and fetal health, today announced the publication of study results using its proprietary prenatal test to accurately identify multiple fetal chromosomal abnormalities from maternal blood. All trisomy 21 and trisomy 18 test samples were classified correctly. The publication, entitled 'Optimal Detection of Fetal Chromosomal Abnormalities Using Massively Parallel...